Deborah Gordon | VP, IR |
James Hollingshead | President, CEO & Director |
Wayde McMillan | EVP, CFO & Treasurer |
Lawrence Biegelsen | Wells Fargo Securities |
Robert Marcus | JPMorgan Chase & Co. |
Malgorzata Kaczor | William Blair & Company |
Joshua Jennings | TD Cowen |
Danielle Antalffy | UBS |
Jeffrey Johnson | Robert W. Baird & Co. |
Michael Sarcone | Jefferies |
Christopher Pasquale | Nephron Research |
Matthew O'Brien | Piper Sandler & Co. |
Matthew Miksic | Barclays Bank |
Steven Lichtman | Oppenheimer |
Joanne Wuensch | Citigroup |
Doyle Shell | Raymond James & Associates |
Travis Steed | Bank of America Merrill Lynch |
Good afternoon, ladies and gentlemen, and welcome to the Insulet Corporation Second Quarter 2023 Earnings Call. [Operator Instructions].
I would now like to turn the conference over to your host, Deborah Gordon, Vice President, Investor Relations.
Thank you. Good afternoon, and thank you joining us for Insulet's Second Quarter 2023 Earnings Call.